Osborne Partners Capital Management’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,000
Closed -$20K 185
2020
Q3
$20K Sell
10,000
-15,000
-60% -$31K ﹤0.01% 155
2020
Q2
$53K Hold
25,000
0.01% 150
2020
Q1
$40K Sell
25,000
-1,000
-4% -$2.58K 0.01% 145
2019
Q4
$58K Hold
26,000
0.01% 154
2019
Q3
$49K Sell
26,000
-10,000
-28% -$29.3K 0.01% 162
2019
Q2
$164K Hold
36,000
0.03% 165
2019
Q1
$164K Sell
36,000
-6,000
-14% -$27.8K 0.03% 163
2018
Q4
$197K Sell
42,000
-15,000
-26% -$74.7K 0.03% 173
2018
Q3
$362K Hold
57,000
0.05% 159
2018
Q2
$386K Hold
57,000
0.05% 156
2018
Q1
$326K Sell
57,000
-11,565
-17% -$80.1K 0.04% 161
2017
Q4
$522K Sell
68,565
-3,263
-5% -$27.9K 0.07% 138
2017
Q3
$673K Buy
+71,828
New +$653K 0.09% 129

Other funds holding IRIX

Osborne Partners Capital Management's IRIX Position: Q4 2020 in Review

Osborne Partners Capital Management sold out of IRIDEX (IRIX) in Q4 2020, closing a stake of 10,000 shares — an estimated $20K sold.

Osborne Partners Capital Management first reported a position in IRIX in Q3 2017 and held it in 13 quarters. The position peaked at $673K in Q3 2017. 22 funds tracked by Wall St. Rank hold IRIX as of Q4 2020.

  • Osborne Partners Capital Management reported no remaining IRIDEX position as of Q4 2020 after selling out during the quarter.
  • Osborne Partners Capital Management sold 10,000 IRIDEX shares in Q4 2020, an estimated $20K.
  • Osborne Partners Capital Management first reported a position in IRIDEX in Q3 2017 and held it in 13 quarters.
  • Osborne Partners Capital Management's IRIDEX position peaked at $673K in Q3 2017.
  • 22 funds tracked by Wall St. Rank held IRIDEX as of Q4 2020.

Based on Osborne Partners Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.